As people’s bodies change due to GLP-1s, so does their spending across industries including fashion, restaurants, gyms and ...

The high-profile Australian start-up more than doubled its revenue in the year ending June 30, driven by strong demand in the ...

President boasted that drug prices were falling ‘700%’, a mathematical impossibility, as a result of his executive actions ...

Meghan Trainor decided to quit drinking coffee after a psychic told her husband, Daryl Sabara, that her caffeine intake was ...

Interest in therapies that support weight management has grown rapidly as new metabolic medicines reshape treatment choices ...

Research is important to us for many reasons. Sometimes, for example, research results in a new treatment (e.g., Alexander ...

The weight loss market has become one of the hottest areas in the pharmaceutical industry. Investors looking to capitalize on ...

Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 ...

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for ...

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without insurance. The drugmaker said Monday that it has started selling higher doses ...

Share on PinterestNovo Nordisk has announced the cessation of the Evoke trials, looking at whether GLP-1 drugs could help ...

The share price of Danish pharmaceutical giant Novo Nordisk ( NVO +1.31%) hit a four-year low Monday, falling below $44 a ...